Persons with dispensed medicines; age and sex
| Sex | Ages | Medicine group (ATC) | Periods | Persons with medicines, relative (%) |
|---|---|---|---|---|
| Total male and female | Total age | A08 Antiobesity prep. excl.diet products | 2024* | 0.02 |
| Total male and female | Total age | A08A Antiobesity prep.excl.diet products | 2024* | 0.02 |
| Total male and female | Total age | A11J Other vitamin products + combinat. | 2024* | 0.00 |
| Total male and female | Total age | A16 Other aliment.tract/metabol.products | 2024* | 0.01 |
| Total male and female | Total age | B05A Blood and related products | 2024* | 0.00 |
| Total male and female | Total age | L01C Plant alkaloids/oth.natural product | 2024* | 0.00 |
| Total male and female | Total age | M02 Topical joint/muscular pain products | 2024* | 0.00 |
| Total male and female | Total age | R07 Other respiratory system products | 2024* | 0.01 |
| Total male and female | Total age | R07A Other respiratory system products | 2024* | 0.01 |
| Total male and female | Total age | V03 All other therapeutic products | 2024* | 0.09 |
| Total male and female | Total age | V03A All other therapeutic products | 2024* | 0.09 |
| Total male and female | Total age | V07 All other non-therapeutic products | 2024* | 0.06 |
| Total male and female | Total age | V07A All other non-therapeutic products | 2024* | 0.06 |
| Total male and female | 0 to 14 years | A08 Antiobesity prep. excl.diet products | 2024* | 0.00 |
| Total male and female | 0 to 14 years | A08A Antiobesity prep.excl.diet products | 2024* | 0.00 |
| Total male and female | 0 to 14 years | A11J Other vitamin products + combinat. | 2024* | 0.00 |
| Total male and female | 0 to 14 years | A16 Other aliment.tract/metabol.products | 2024* | 0.02 |
| Total male and female | 0 to 14 years | B05A Blood and related products | 2024* | 0.00 |
| Total male and female | 0 to 14 years | L01C Plant alkaloids/oth.natural product | 2024* | 0.00 |
| Total male and female | 0 to 14 years | M02 Topical joint/muscular pain products | 2024* | 0.00 |
| Total male and female | 0 to 14 years | R07 Other respiratory system products | 2024* | 0.01 |
| Total male and female | 0 to 14 years | R07A Other respiratory system products | 2024* | 0.01 |
| Total male and female | 0 to 14 years | V03 All other therapeutic products | 2024* | 0.01 |
| Total male and female | 0 to 14 years | V03A All other therapeutic products | 2024* | 0.01 |
| Total male and female | 0 to 14 years | V07 All other non-therapeutic products | 2024* | 0.02 |
| Total male and female | 0 to 14 years | V07A All other non-therapeutic products | 2024* | 0.02 |
| Total male and female | 15 to 24 years | A08 Antiobesity prep. excl.diet products | 2024* | 0.00 |
| Total male and female | 15 to 24 years | A08A Antiobesity prep.excl.diet products | 2024* | 0.00 |
| Total male and female | 15 to 24 years | A11J Other vitamin products + combinat. | 2024* | 0.00 |
| Total male and female | 15 to 24 years | A16 Other aliment.tract/metabol.products | 2024* | 0.01 |
| Total male and female | 15 to 24 years | B05A Blood and related products | 2024* | 0.00 |
| Total male and female | 15 to 24 years | L01C Plant alkaloids/oth.natural product | 2024* | 0.00 |
| Total male and female | 15 to 24 years | M02 Topical joint/muscular pain products | 2024* | 0.00 |
| Total male and female | 15 to 24 years | R07 Other respiratory system products | 2024* | 0.01 |
| Total male and female | 15 to 24 years | R07A Other respiratory system products | 2024* | 0.01 |
| Total male and female | 15 to 24 years | V03 All other therapeutic products | 2024* | 0.01 |
| Total male and female | 15 to 24 years | V03A All other therapeutic products | 2024* | 0.01 |
| Total male and female | 15 to 24 years | V07 All other non-therapeutic products | 2024* | 0.01 |
| Total male and female | 15 to 24 years | V07A All other non-therapeutic products | 2024* | 0.01 |
| Total male and female | 25 to 34 years | A08 Antiobesity prep. excl.diet products | 2024* | 0.01 |
| Total male and female | 25 to 34 years | A08A Antiobesity prep.excl.diet products | 2024* | 0.01 |
| Total male and female | 25 to 34 years | A11J Other vitamin products + combinat. | 2024* | 0.00 |
| Total male and female | 25 to 34 years | A16 Other aliment.tract/metabol.products | 2024* | 0.01 |
| Total male and female | 25 to 34 years | B05A Blood and related products | 2024* | 0.00 |
| Total male and female | 25 to 34 years | L01C Plant alkaloids/oth.natural product | 2024* | 0.00 |
| Total male and female | 25 to 34 years | M02 Topical joint/muscular pain products | 2024* | 0.00 |
| Total male and female | 25 to 34 years | R07 Other respiratory system products | 2024* | 0.01 |
| Total male and female | 25 to 34 years | R07A Other respiratory system products | 2024* | 0.01 |
| Total male and female | 25 to 34 years | V03 All other therapeutic products | 2024* | 0.02 |
| Total male and female | 25 to 34 years | V03A All other therapeutic products | 2024* | 0.02 |
| Total male and female | 25 to 34 years | V07 All other non-therapeutic products | 2024* | 0.01 |
| Total male and female | 25 to 34 years | V07A All other non-therapeutic products | 2024* | 0.01 |
| Total male and female | 35 to 44 years | A08 Antiobesity prep. excl.diet products | 2024* | 0.03 |
| Total male and female | 35 to 44 years | A08A Antiobesity prep.excl.diet products | 2024* | 0.03 |
| Total male and female | 35 to 44 years | A11J Other vitamin products + combinat. | 2024* | 0.00 |
| Total male and female | 35 to 44 years | A16 Other aliment.tract/metabol.products | 2024* | 0.01 |
| Total male and female | 35 to 44 years | B05A Blood and related products | 2024* | 0.00 |
| Total male and female | 35 to 44 years | L01C Plant alkaloids/oth.natural product | 2024* | 0.00 |
| Total male and female | 35 to 44 years | M02 Topical joint/muscular pain products | 2024* | 0.00 |
| Total male and female | 35 to 44 years | R07 Other respiratory system products | 2024* | 0.01 |
| Total male and female | 35 to 44 years | R07A Other respiratory system products | 2024* | 0.01 |
| Total male and female | 35 to 44 years | V03 All other therapeutic products | 2024* | 0.03 |
| Total male and female | 35 to 44 years | V03A All other therapeutic products | 2024* | 0.03 |
| Total male and female | 35 to 44 years | V07 All other non-therapeutic products | 2024* | 0.02 |
| Total male and female | 35 to 44 years | V07A All other non-therapeutic products | 2024* | 0.02 |
| Total male and female | 45 to 54 years | A08 Antiobesity prep. excl.diet products | 2024* | 0.05 |
| Total male and female | 45 to 54 years | A08A Antiobesity prep.excl.diet products | 2024* | 0.05 |
| Total male and female | 45 to 54 years | A11J Other vitamin products + combinat. | 2024* | 0.00 |
| Total male and female | 45 to 54 years | A16 Other aliment.tract/metabol.products | 2024* | 0.01 |
| Total male and female | 45 to 54 years | B05A Blood and related products | 2024* | 0.00 |
| Total male and female | 45 to 54 years | L01C Plant alkaloids/oth.natural product | 2024* | 0.00 |
| Total male and female | 45 to 54 years | M02 Topical joint/muscular pain products | 2024* | 0.00 |
| Total male and female | 45 to 54 years | R07 Other respiratory system products | 2024* | 0.01 |
| Total male and female | 45 to 54 years | R07A Other respiratory system products | 2024* | 0.01 |
| Total male and female | 45 to 54 years | V03 All other therapeutic products | 2024* | 0.06 |
| Total male and female | 45 to 54 years | V03A All other therapeutic products | 2024* | 0.06 |
| Total male and female | 45 to 54 years | V07 All other non-therapeutic products | 2024* | 0.03 |
| Total male and female | 45 to 54 years | V07A All other non-therapeutic products | 2024* | 0.03 |
| Total male and female | 55 to 64 years | A08 Antiobesity prep. excl.diet products | 2024* | 0.04 |
| Total male and female | 55 to 64 years | A08A Antiobesity prep.excl.diet products | 2024* | 0.04 |
| Total male and female | 55 to 64 years | A11J Other vitamin products + combinat. | 2024* | 0.00 |
| Total male and female | 55 to 64 years | A16 Other aliment.tract/metabol.products | 2024* | 0.01 |
| Total male and female | 55 to 64 years | B05A Blood and related products | 2024* | 0.00 |
| Total male and female | 55 to 64 years | L01C Plant alkaloids/oth.natural product | 2024* | 0.00 |
| Total male and female | 55 to 64 years | M02 Topical joint/muscular pain products | 2024* | 0.00 |
| Total male and female | 55 to 64 years | R07 Other respiratory system products | 2024* | 0.00 |
| Total male and female | 55 to 64 years | R07A Other respiratory system products | 2024* | 0.00 |
| Total male and female | 55 to 64 years | V03 All other therapeutic products | 2024* | 0.11 |
| Total male and female | 55 to 64 years | V03A All other therapeutic products | 2024* | 0.11 |
| Total male and female | 55 to 64 years | V07 All other non-therapeutic products | 2024* | 0.06 |
| Total male and female | 55 to 64 years | V07A All other non-therapeutic products | 2024* | 0.06 |
| Total male and female | 65 to 74 years | A08 Antiobesity prep. excl.diet products | 2024* | 0.02 |
| Total male and female | 65 to 74 years | A08A Antiobesity prep.excl.diet products | 2024* | 0.02 |
| Total male and female | 65 to 74 years | A11J Other vitamin products + combinat. | 2024* | 0.00 |
| Total male and female | 65 to 74 years | A16 Other aliment.tract/metabol.products | 2024* | 0.02 |
| Total male and female | 65 to 74 years | B05A Blood and related products | 2024* | 0.00 |
| Total male and female | 65 to 74 years | L01C Plant alkaloids/oth.natural product | 2024* | 0.00 |
| Total male and female | 65 to 74 years | M02 Topical joint/muscular pain products | 2024* | 0.00 |
| Total male and female | 65 to 74 years | R07 Other respiratory system products | 2024* | 0.00 |
| Total male and female | 65 to 74 years | R07A Other respiratory system products | 2024* | 0.00 |
| Source: CBS. | ||||
Table explanation
This table contains figures on the absolute number of persons to whom in the year concerned medicines were dispensed for which the costs are reimbursed under the statutory basic medical insurance. Also, the number of dispensed defined daily doses (DDDs) are presented. The figures are also expressed as a percentage of the total population in the category concerned. The population includes everybody registered in the Personal Records Database (BRP) and living in the Netherlands at some point in the year concerned. Until 2010 the figures also included medicines dispensed to persons registered in the BRP, but no longer resident in the Netherlands.
Medicines provided to persons in hospitals and nursing homes are not included; medicines provided in residential homes for the elderly are included.
Data are broken down by medicine group, age and sex.
Data available from: 2006
Status of the figures:
Figures for 2024 are provisional, figures for previous years are final.
Changes as of December 18, 2025:
- Provisional figures for 2024 have been added, provisional figures of 2023 have been made definite.
- Figures for 2024 do not include DDD's as they are insufficiently reliable.
When will new figures be published?
New figures will be published in the last quarter of 2026.
Description topics
- Persons with medicines, relative
- Number of persons to whom medicines are dispensed in the year concerned that are reimbursed under the statutory basic medical insurance, expressed as a percentage of the total population of the category concerned registered in the Basic Registration of Persons (BRP) in that year.